Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.24.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive.

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Warrants

 

 

 

4,625,000

 

 

 

14,395,591

 

 

 

4,625,000

 

 

 

14,395,591

 

Stock options

 

 

 

5,316,451

 

 

 

3,546,340

 

 

 

5,316,451

 

 

 

3,546,340

 

Convertible notes

 

 

 

3,818,611

 

 

 

3,472,838

 

 

 

104,218,359

 

 

 

90,350,622

 

Total anti-dilutive instrument

 

 

 

13,760,062

 

 

 

21,414,769

 

 

 

114,159,810

 

 

 

108,292,553